Lyvgen Biopharma Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Lyvgen Biopharma is a cross-linking-dependent antibody platform. The company also provides tumor immune agonistic antibody, local activation of the tumor microenvironment, and synthetic biology engineering services.

Company Highlights
Year Founded

2016

icon-altEmployees

21

Location (HQ)

CHN

Since Last Funding

3 years 8 months

Monthly Website Visitors

2.1K

icon-altTotal Investment Amt

$40M

Last Funding Round

Series C

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Medical

Biotechnology Research

Biopharma